A. Cellular and Subcellular Localization B. Pharmacological Tools to Study Adenosine
Receptors C. Signaling Via Adenosine Receptors D. Regulation of Receptor Expression and …

Adenosine is a neuromodulator that operates via the most abundant inhibitory adenosine A
1 receptors (A 1 Rs) and the less abundant, but widespread, facilitatory A 2A Rs. It is …

The existence of A 2A-D 2 heteromeric complexes is based on coimmunoprecipitation
studies and on fluorescence resonance energy transfer and bioluminescence resonance …

In the pursuit of improved treatments for Parkinson's disease (PD), the adenosine A2A
receptor has emerged as an attractive nondopaminergic target. Based on the compelling …

Adenosine A2A receptors are most abundant in the striatum where they control the
striatopallidal pathway thus controlling locomotion. Extra-striatal A2A receptors are …

The anti‐Parkinsonian effect of glutamate metabotropic group 5 (mGluR5) and adenosine
A2A receptor antagonists is believed to result from their ability to postsynaptically control the …

Adenosine receptors represent a family of G‐protein coupled receptors that are ubiquitously
expressed in a wide variety of tissues. This family contains four receptor subtypes: A1 and …

The development of non-dopaminergic therapies for the treatment of Parkinson's disease
(PD) has attracted much interest in recent years. Among new different classes of drugs …

Markers of serotonergic, γ‐aminobutyric acid (GABA)‐ergic (glutamic acid decarboxylase,
67 kDa isoform; GAD‐67), and glutamatergic transmission (vesicular glutamate transporter …

Objectives: We reviewed our most recent work on the protective effect of adenosine
A2Aantagonism in cerebral ischemia. Methods: Focal ischemia was produced in rats by …